Diclofenac Sodium Tablet, Delayed Release
Product Images NDC 68071-3184

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 68071-3184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 3184 6

Label for Diclofenac Sodium Delayed Release Tablets 50 mg by NuCare Pharmaceuticals, Inc. The label indicates a bottle containing 60 round white/off-white tablets imprinted with "CTI 102." It includes product and manufacturing details, dosage form as delayed-release oral tablets, storage instructions, and a warning to keep out of reach of children.*

FDA Label Image

Structural Formula (Dic05 0004 01)

Chemical structure of Diclofenac Sodium, the active ingredient in Diclofenac Sodium Delayed Release tablets. The diagram shows two aromatic rings with chlorine substitutions and a carboxylate group.*

FDA Label Image

Cti 102 Imprint (Dic05 0004 03)

Chemical structure of Diclofenac Sodium, shown as a 2D molecular diagram of the compound's atomic and bond arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.